PI
Pennant Investors Portfolio holdings
AUM
$334M
This Quarter Return
+12.76%
1 Year Return
+56.91%
3 Year Return
+148.85%
5 Year Return
+226.03%
10 Year Return
–
AUM
$366M
AUM Growth
+$366M
(+1.3%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-4.85%
Top 10 Holdings %
Top 10 Hldgs %
88.42%
Holding
50
New
6
Increased
1
Reduced
5
Closed
4
Top Buys
| 1 |
Micron Technology
MU
|
$16.4M |
| 2 |
Valmont Industries
VMI
|
$11M |
| 3 |
GE Vernova
GEV
|
$10.3M |
| 4 |
Vertiv
VRT
|
$9.96M |
| 5 |
Iris Energy
IREN
|
$5.31M |
Top Sells
| 1 |
Enovis
ENOV
|
$25M |
| 2 |
Microsoft
MSFT
|
$14.3M |
| 3 |
TransDigm Group
TDG
|
$12.3M |
| 4 |
Amazon
AMZN
|
$10.8M |
| 5 |
Antero Resources
AR
|
$9.69M |
Sector Composition
| 1 | Technology | 26.51% |
| 2 | Industrials | 19.87% |
| 3 | Communication Services | 19.57% |
| 4 | Consumer Discretionary | 16.95% |
| 5 | Energy | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Micron Technology
MU
$133B
| $56.7M | 14.82% | 431,000 +125,000 | +41% | +$16.4M |
|
|
2
Amazon
AMZN
$2.44T
| $46.4M | 12.12% | 240,000 -56,000 | -19% | -$10.8M |
|
|
3
TransDigm Group
TDG
$78.8B
| $41.4M | 10.81% | 32,371 -9,629 | -23% | -$12.3M |
|
4
EchoStar
SATS
$17.8B
| $38.3M | 10.02% | 2,153,209 | – | – |
|
|
5
Microsoft
MSFT
$3.77T
| $35.8M | 9.35% | 80,000 -32,000 | -29% | -$14.3M |
|
6
Alphabet (Google) Class A
GOOGL
$2.57T
| $33.3M | 8.71% | 183,000 -16,000 | -8% | -$2.91M |
|
|
7
Antero Resources
AR
$9.86B
| $27.3M | 7.13% | 836,000 -297,000 | -26% | -$9.69M |
|
8
Perimeter Solutions
PRM
$3.28B
| $18M | 4.71% | 2,300,000 | – | – |
|
9
ODP
ODP
$610M
| $15.7M | 4.11% | 400,000 | – | – |
|
|
10
Valmont Industries
VMI
$7.25B
| $11M | 2.87% | +40,000 | New | +$11M |
|
|
11
GE Vernova
GEV
$167B
| $10.3M | 2.69% | +60,000 | New | +$10.3M |
|
|
12
Vertiv
VRT
$48.7B
| $9.96M | 2.6% | +115,000 | New | +$9.96M |
|
|
13
Iris Energy
IREN
$6.4B
| $5.31M | 1.39% | +470,000 | New | +$5.31M |
|
14
Core Scientific
CORZ
$4.38B
| $4.65M | 1.22% | +500,000 | New | +$4.65M |
|
15
Arcutis Biotherapeutics
ARQT
$1.86B
| $1.59M | 0.42% | 170,900 | – | – |
|
16
Nurix Therapeutics
NRIX
$714M
| $1.19M | 0.31% | 56,800 | – | – |
|
17
Novavax
NVAX
$1.21B
| $763K | 0.2% | 60,300 | – | – |
|
18
Altimmune
ALT
$338M
| $730K | 0.19% | 109,800 | – | – |
|
19
FibroGen
FGEN
$47.8M
| $686K | 0.18% | 768,400 | – | – |
|
20
Agios Pharmaceuticals
AGIO
$2.19B
| $651K | 0.17% | 15,100 | – | – |
|
21
Fate Therapeutics
FATE
$120M
| $479K | 0.13% | 146,100 | – | – |
|
22
Travere Therapeutics
TVTX
$1.56B
| $459K | 0.12% | +55,800 | New | +$459K |
|
23
Enanta Pharmaceuticals
ENTA
$180M
| $455K | 0.12% | 35,100 | – | – |
|
|
IGMS
24
DELISTED
IGM Biosciences
IGMS
| $446K | 0.12% | 64,900 | – | – |
|
25
Erasca
ERAS
$445M
| $392K | 0.1% | 166,200 | – | – |
|